Patient
SITE009-0089
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2025-12-21
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-03
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-27 (study day 216); relationship: NOT RELATED
mild
assessed
2026-06-10
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-04 (study day 162); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.